Lung cancer drug response tied to tumor type: study (Reuters)
Reuters – Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for successful treatment, according to results from a recent trial.
View full post on Yahoo! News: Most Popular
Leave a Reply